Ventricular Tachyarrhythmias in Implantable Cardioverter Defibrillator Recipients: Differences Between Ischemic and Dilated Cardiomyopathies by Aldo Casaleggio et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors




the world’s leading publisher of
Open Access books






Ventricular Tachyarrhythmias in Implantable 
Cardioverter Defibrillator Recipients: 
Differences Between Ischemic and Dilated 
Cardiomyopathies 
Aldo Casaleggio1, Tiziana Guidotto2, Vincenzo Malavasi3 and Paolo Rossi4 
1National Research Council, Biophysics Institute, Genova, 
 2St. Jude Medical Italia, Clinical Department, Agrate Brianza, Milano,  
 3Modena Polyclinic Hospital, Cardiology Division, Modena, 
4San Martino Hospital, Cardiology Division, Genova, 
Italy 
1. Introduction 
Progress in implantable cardioverter-defibrillator (ICD) technology has led to significant 
improvements in the management of malignant ventricular tachyarrhythmias (VT) from 
patients with different etiologies [Henkel & Witt 2006, Javaray & Monahan 2005]. Figure 1 
depicts the case of a patient who experienced a malignant ventricular fibrillation rapidly 
resolved by the ICD. 
 
 
Fig. 1. Example of malignant ventricular tachycardia degenerating in ventricular fibrillation, 
automatically recognized and treated by the ICD. 
In addition, the ability of these devices to record and store information on electrical cardiac 
activity immediately preceding the arrhythmia onset and during its course has enabled the 
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assessment of the initiation pattern and characteristics of these arrhythmias. Eventually, at 
the end of the nineties, it has been shown that coronary artery disease (CAD) and dilated 
cardiomyopathy (DCM) underlie different mechanisms of spontaneous and induced VT 
[Pogwizd et al. 1998, Chung et al. 1997]; moreover ,differences in spontaneous VT from ICD 
recipients began to be investigated. Indeed, since the early 2000, various studies have 
analyzed intracardiac electrograms (EGMs) and initiation VT pattern [Gorenek et al. 2006, 
Taylor et al. 2000, Saeed et al. 2000], while others have investigated circadian distribution 
[Carson et al. 2000, Englund et al. 1999, Eksik et al. 2007, Taneda et al. 2001] of spontaneous 
VT in ICD patients. Some of these studies [Taylor et al. 2000, Saeed et al. 2000, Englund et al. 
1999] have failed to detect differences in both the patterns of initiation and in EGMs between 
patients with different etiologies of heart disease. In contrast, differences in the circadian 
distribution were detected in other studies [Carson et al. 2000, Taneda et al. 2001], showing 
that patients with CAD had a peak of the VT episodes in the morning, whereas patients with 
non-ischemic cardiomyopathy and heart failure had a more uniform VT distribution during 
the light hours and a few episodes during the night. The main limitation of these studies lies 
in their definition of non-ischemic cardiomyopathy, which included different cardiac 
diseases such as dilated cardiomyopathy, hypertrophic cardiomyopathy, valvular heart 
disease, right ventricular dysplasia and others.  
Unlike previous studies, this study focuses exclusively on patients with CAD and those with 
DCM. Therefore, by analyzing spontaneous VT from ICDs, we sought to determine whether 
there were differences in EGM characteristics obtained from far-field recordings, VT 
prevalence, initiation patterns and circadian distribution between patients with CAD and 
DCM. A subset of this study was preliminarily presented [Casaleggio et al. 2008]. 
2. Methods 
2.1 Electa registry 
Sixty-seven patients were enrolled in the ElectA Registry (Electrogram Analysis) which 
included subjects undergoing implantation of St. Jude Medical single chamber ICD devices 
(models: Contour, Profile and Angstrom) for secondary prevention of aborted sudden 
cardiac death (SCD) due to ventricular fibrillation or sustained VT episodes (with duration 
greater than 30 sec). Among them, 46 had ischemic cardiomyopathy due to CAD, 17 had 
primary DCM and 4 had other etiology: one Brugada Syndrome, one RV Dysplasia and two 
hypertrophic cardiomyopathies.  
ICDs allowed acquisitions of the EGMs in bipolar or far-field modes. In bipolar mode, EGMs 
were recorded between distal coil and electrocatheter tip at the right ventricular lead tip, 
and filtered with an high pass at 12 Hz. In far-field mode, EGMs were recorded between the 
distal coil and the active can of the device without low frequency filtration. In our previous 
study [Casaleggio et al. 2006], we examined the differences between bipolar and far-field 
recordings, and observed that the two modes of acquisition should not be combined to 
avoid characterization errors. Furthermore, far-field recordings easily recognized pacing 
beats, allowed a better definition of the T-wave in sinus rhythm and a higher discrimination 
of the QRS morphology for the off-line diagnosis of VT (see Figure 2). 
In order to study VT-onset, ICDs were programmed to store EGMs of 2 minutes at a 
sampling frequency of 250 Hz, that allowed up to three EGMs recordings on a single 
channel at each follow-up. Moreover, since storage was triggered on VT initiation (when VT 
is shorter than 2 minutes), the protocol required a pre-trigger of 20 sec. at minimum to  
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Fig. 2. Schematic of bipolar and far-field EGMs from ICDs. In the right side of the panel the 
main characteristics of the two types of recordings are described and examples are shown. 
monitor basal rhythm immediately before VT initiation. Patients gave written consent for 
the implantation , follow-up and planned evaluations; they were identified by their ICD 
serial numbers. Patients were excluded from the ElectA study if they had an indication to 
dual-chamber ICD implantation, or refused to consent. ICD settings were at the discretion of 
the physician, except for a pre-trigger at 20 seconds. No requirements were proposed either 
for VT- therapy (rate cutoff and monitoring zone) or bradycardia pacing, although all 
clinicians programmed a lower rate in VVI mode at 50-60 beats per minute. 
Clinical information for each patient including age, gender, heart disease, left ventricular 
ejection fraction, and antiarrhythmic drug therapy at the time of ICD implant, were 
documented by review of clinical records. Information on VT events and circadian 
distribution were retrieved from the log file of the ICD device. ICD follow-up was routinely 
performed every 3-4 months and whenever patients felt palpitations, dizziness or shock. 
2.2 Patient population 
The present study focused only on patients with CAD or DCM. The CAD group included 46 
patients (26 of which had VT episodes) with a history of previous myocardial infarction, 
angina, coronary angioplasty or coronary by-pass surgery. The DCM group included 17 
patients (11 of which had VT episodes) with progressive cardiac dilation and left ventricular 
systolic dysfunction (ejection fraction less than 0.40), without significant CAD defined as 
greater than 50% stenosis in at least one vessel by coronary angiography. In all patients 
secondary etiology was excluded by clinical evaluation of potential causes such as 
alcoholism, thyroid disease, viral infection of the heart, valvular heart abnormalities, 
heredofamilial disease, or toxic drugs. No endomyocardial biopsy was obtained. 
The baseline characteristics of CAD and DCM patients that experienced spontaneous 
malignant VT episodes are reported in Table 1.  
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 CAD DCM p 
N. of patients with VT 26 11  
Clinical Characteristics    
Age (years) 70 ± 10 64 ± 12 n.s. () 
Gender (male/female) 23 / 3 10 / 1 n.s. () 
Follow-up (months) 33 ± 10 24 ± 13 <0.03 () 
Ejection Fraction (%) 35 ± 8 31 ± 9 n.s. () 
NYHA Class: I / II+III (n) 2 / 24 2 / 9 n.s. () 
Basal rhythm: 
Sinus / Atrial fibrillation (n) 
 
23 / 3 
 
8 / 3 
 
n.s. () 
Treatment at ICD implant: 
Amiodarone , n (%) 
Beta-blockers , n (%) 
Amiodarone + Beta-blockers , n (%) 













Table 1. Clinical Characteristics of CAD and DCM patients with VT episodes; () Statistical 
analysis performed with Student T-test; () Statistical analysis performed by chi-square test. 
2.3 Modes of VT initiation and evaluated EGM characteristics 
All VT episodes (monomorphic and polymorphic VT and ventricular fibrillation) were 
analyzed by cardiologists. VT were identified by a sudden increase in heart rate (defined 
as a rhythm greater than 140 beats per minute) along with a change in EGM morphology 
from the baseline rhythm. Arrhythmias due to atrial fibrillation or atrial flutter were 
excluded from the analysis. Using EGMs, VT initiation was characterized as follows: VT 
initiated by a premature ventricular contraction (PVC), defined as PVC pattern (Fig. 3A); 
VT initiated by a short-long-short cycle (SLS pattern, Fig. 3B); VT initiated with a PVC 
immediately after a paced ventricular beat (PM pattern, Fig. 3C). The pause preceding 
paced beats was considered appropriate if it was consistent with the programmed pacing 
escape interval.  
For each VT episode the following features were analyzed: (i) VT-cycle defined as the 
median value of the VT cycles, in milliseconds (msec); (ii) Coupling interval (CI) taken as the 
interval between the first beat of VT and the previous baseline beat, in msec; (iii) Prematurity 
index (PI) calculated by normalizing the coupling interval to the preceding RR interval; (iv) 
Median heart cycle of the 20 seconds immediately preceding VT onset (HC-PreVT), in msec; 
(v) number of PVC and (vi) number of paced beats in the 20 sec preceding VT. The 
morphological analysis of PVC and VT was not considered.  
Circadian distribution analysis was made over a 3 hour time interval, performing a 
sufficiently detailed analysis and an adequate number of VT episodes in each time interval. 
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Fig. 3. Examples of tachyarrhythmia initiation patterns from ICD recordings: Panel (A) 
shows a PVC onset, Panel (B) is a short-long-short (SLS) onset, Panel (C) illustrates a 
tachyarrhythmia initiated immediately after a paced beat (PM onset); Numbers between R-
peaks indicate RR intervals in msec.  
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2.4 Statistical analysis 
Intervals and continuous variables are expressed as mean + standard deviation. Differences 
between groups are analyzed using the Student T-test for continuous variables or the Chi-
square test for categorical variables. Statistical significance is assumed when p<0.05. The 
number of VT per patient, and the number and type of VT-onset experienced by the 
patients, are considered together with their average values. Differences between average 
values are analyzed using the Student T-test. 
Circadian distributions are modeled by polynomial (fifth order) and harmonic regression 
(two harmonics). It is expected that distributions with peaks and dumb-peaks can better be 
fitted by harmonic models, while smooth distributions would be better modeled as 
polynomials. Goodness of fit of the regression models has been tested using the coefficient 
of determination 2R , defined as in equation (1): 
 
2













  (1) 
In equation (1) the value of iy  represents the measured variable for each 3-hour interval, iy  
is its mean value, and ˆ iy  is the approximation obtained by the regression model. No formal 
sample size calculation has been performed. 
3. Results 
A total of 218 VT episodes were recorded in far-field mode during a follow up period of 30 ± 
12 months. The analysis included all VT episodes requiring ICD therapy by antitachycardia 
pacing or shock cardioversion, as well as non-treated VT that recovered spontaneously. In 
particular 165 VT episodes which occurred in 37 patients, including 26 CAD patients (79 
episodes) and 11 DCM patients (86 VT episodes) were analyzed. The remaining 53 VT 
episodes, (29 from DCM and 24 from CAD patients) could not be analyzed because, lasting 
more than 2 minutes, VT initiation was not available for ICD programmable setting. No 
under-sensing was observed. 
As shown in Table 2, there were significant differences between CAD and DCM patients 
with VT episodes. In particular, DCM patients experienced a significantly higher number of 
VT episodes and more variable pattern of VT initiation.  
Table 3 presents the statistical analysis of EGM features associated with specific VT 
initiation patterns in patients with CAD or DCM. There were no significant differences 
between CAD and DCM groups. However, within each group, the SLS and PM patterns 
showed a significantly lower prematurity index than the PVC pattern. In addition, the PM 
pattern demonstrated a significantly longer heart cycle preVT versus PVC and SLS (p < 
0.01). 
Figures 4 and 5 depict the circadian distributions of VT episodes in CAD and DCM patients, 
with an analysis in the overall groups (Fig. 4) and in subgroups with different patterns of VT 
initiation (Fig. 5). Figure 4 shows the presence of the two peaks in CAD patients, and a more 
uniformly distribution during daylight hours with a few VT episodes during the night in 
DCM patients.  
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 CAD DCM P 
Number  of patients with VT 26 11  
Analysis of the 20 sec basal rhythm preceding VT-onset 
     Paced beats / All beats  
     Premature ventricular contraction / All beats  
 
1 / 28 
2 / 27 
 
1 / 27 
3 /27 
 
n.s. ( )  
n.s. ( )  
Analysis of VT episodes 
     Number of VT episodes 
     Number of VT episodes per patient, mean ±SD 
 
79 
3 ± 2 
 
86 
8 ± 5 
 
 
<0.02 ( )  
Analysis of the VT-onset patterns      
     Total number of  VT per pattern: 
 PVC,  n (%) 
 SLS,  n (%) 
 PM,  n (%) 
     Number of  patients with 1, 2 or 3 patterns: 
 Patients with a single initiation pattern,  n (%) 
 Patients with two initiation patterns,  n (%) 
 Patients with three initiation patterns,  n (%) 
 





























( )0.01   
Table 2. Analysis of VT episodes in patients with CAD or DCM ; Different statistical tests 
were applied: () Statistical analysis is performed with Student T-test; () Statistical analysis is 
performed by chi-square test;  () chi-square test is done on 3x2 table to test different Number 
of VT per pattern in CAD vs. DCM; () chi-square test is computed on 3x2 table to test 
different Number of patients with 1, 2 or 3 patterns  in CAD vs. DCM patients. 
 
 CAD Patients DCM Patients 
VT onset  PVC SLS PM PVC SLS PM 
# of Episodes 59 13 7 51 22 13 




























Table 3. EGM features associated with specific VT onset patterns in patients with CAD or 
DCM. Statistical significance is indicated as follows: * p <0.01 versus PVC within the same 
etiology group; + p<0.01 versus SLS within the same etiology group. Legend: VT patterns 
are defined as follows: PVC: VT initiated by a premature ventricular contraction; SLS: VT 
initiated by a short-long-short cycle; PM: VT initiated with a PVC immediately after a paced 
beat. CAD: coronary artery disease; DCM: dilated cardiomyopathy; CI: coupling interval, PI: 
prematurity index, HC-PreVT: heart cycle in the 20 seconds preceding VT-onset. 
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Fig. 4. Circadian distribution over a 3 hour time interval of CAD and DCM patients along 
with polynomial (dashed line) and harmonic (solid line) regression models. 
 
 
Fig. 5. Circadian distribution over a 3 hour time interval of CAD and DCM patients 
separated for the three different modes of onset. Corresponding polynomial (dashed line) 
and harmonic (solid line) regression models are shown. 
To substantiate the observation that CAD and DCM population have different circadian 
distribution of VT episodes, the coefficients of determination (R2), corresponding to the 
harmonic and polynomial regression models depicted in Figure 4, are computed. VT 
circadian distribution of CAD patients is better approximated by a harmonic model 
(R2=0.963 vs. R2=0.767 of polynomial regression). In DCM patients, harmonic and 
polynomial regression lead to similar R2 values (R2=0.983 vs. R2=0.997, respectively), 
although the higher R2 value is obtained approximating circadian distribution using a 
polynomial model.  
Finally, determination coefficients of circadian distributions computed for homogeneous VT 
initiation pattern (PVC, SLS and PM) are resumed in Table 4. 
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 CAD Patients DCM Patients 
 PVC SLS PM PVC SLS PM 
Harmonic model 0.84 0.92 0.71 0.78 0.91 0.85 
Polynomial model 0.83 0.77 0.9 0.86 0.68 0.98 
Table 4. Determination coefficient for harmonic and polynomial regressions: differences 
between CAD and DCM patients with similar VT-initiation patterns. Better performances 
are indicated in bold. 
4. Discussion 
The aim of this study was to determine whether there were differences in spontaneous VT 
initiation patterns and circadian distribution between ICD patients with CAD and DCM. 
Analysis of VT onset identified episodes triggered by a premature beat and two patterns of 
VT preceded by short-long-short cycles. The latter includes the SLS onset, which can be 
viewed as a spontaneous form, and the PM onset in which the ICD device facilitates VT 
initiation during anti-bradycardia pacing.  
Significant differences between CAD and DCM were observed in the number of VT per 
patient and in the variability of the VT onset pattern (see Table 2). Patients with DCM had a 
significantly higher number of VT episodes despite clinical characteristics, ejection fraction 
and NYHA class were similar to CAD patients. It should be noted, as reported in Table 1, 
that the duration of follow-up was significantly longer in the CAD group, making the 
observation of a lower number of VT episodes in this group even more significant. 
Other EGM features such as VT-rate, coupling interval and prematurity index, as well as 
those obtained from the EGM in the 20 sec preceding VT-onset (heart cycle, average number 
of PVC and of paced beats) were also studied (see Table 2 and 3) and, consistent with 
previous observations, no significant differences between CAD and DCM groups were 
observed. This might indicate that the studied EGM parameters do not express the intrinsic 
differences in the cardiac substrate of the two etiologies, as they are shown in the literature 
[Pogwizd et al. 1998, Sarter et al. 1998]. 
4.1 VT initiation patterns 
In the literature the PVC onset is the most frequent mode of VT initiation [Taylor et al. 
2000, Saeed et al. 2000]; SLS onset has been described as an arrhythmogenic mechanism 
[El-Sherif et al. 1999] distinct from PVC onset also in ICD recipients [Sarter et al. 1998]. 
Finally PM onset, observed only in case studies at the end of the nineties [Vlay & Vlay 
1997], has been observed recently to occur in 8% – 15% of VT episodes in ICD patients 
[Sweeney et al. 2007]. 
Premature ventricular contraction (PVC) was the most frequent VT initiation pattern, 
especially in CAD patients.  
Our results are consistent with findings from other authors [Gorenek et al. 2006, Taylor et al. 
2000, Saeed et al. 2000], who underscored the importance of the initiation pattern of 
sustained VT in patients with ICDs. Gorenek et al. [Gorenek et al. 2006] and Saeed et al. 
[Saeed et al. 2000] analyzed the differences between VT onset preceded by several 
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immediate PVCs (denominated extrasystolic onset) and VT with sudden onset, showing that 
extrasystolic onset was the most common pattern of VT initiation and was associated with 
lower ejection fraction. Sudden-onset initiation was more common with better preserved 
systolic function. Non sudden onset episodes required higher levels of shock energy and 
more frequent multiple shock achievements than sudden onset episodes [Gorenek et al. 
2006].  
In the present study the analysis of the modes of VT-onset indicated that 12% of VT initiate 
immediately after a paced beat, which may suggest a proarrhythmic effect of pacing in some 
patients [Sweeney et al. 2007, Himmrich et al. 2003]. These results are consistent with recent 
findings: Sweeney et al [Sweeney et al. 2007] found a 9.4% rate of VT initiated immediately 
after anti-bradycardia pacing in patients with a single chamber ICD, such as those used in 
our study. In our study the prevalence of VT with PM-onset was higher in DCM (15%) than 
CAD (9%), but statistical analysis with chi-square test shows that this difference is not 
significant (p<0.28). On the contrary, a statistically significant difference between CAD and 
DCM populations is obtained from the analysis of the number of initiation pattern 
indicating a more heterogeneous VT-onset in DCM patients (see Table 2). In particular, in 3 
DCM patients all the three initiation patterns are present, while most of CAD initiated their 
VT always with the same mode. 
Results in Table 3 indicate EGM features do not allow discriminating differences between 
CAD and DCM, suggesting that EGM features do not correlate with the cardiac disease 
substrate. However, in each group, significantly higher prematurity index and median heart 
cycle PreVT were observed in VT with PM-onset with respect to other VT initiation modes. 
The HC_PreVT can be explained by observing that anti-bradycardia pacing is a consequence 
of a low spontaneous heart rate. The significantly higher PI of PM-onset episodes, observed 
both in CAD and DCM patients, deserves further investigation. 
4.2 Circadian distribution 
In the literature the circadian distributions of VT episodes in the CAD population has been 
studied and a non-uniform distribution with clear peaks in the morning and afternoon has 
been observed [Englund et al. 1999, Eksik et al. 2007]. Results are controversial in the case of 
non-ischemic patients. While in some papers [Englund et al. 1999, Anand et al. 2007] non-
ischemic disease presents circadian distribution similar to ischemic patients, in other studies 
[Carson et al. 2000, Taneda et al. 2001] non-ischemic patients do not have the morning peak 
and circadian distribution is almost uniformly distributed during daylight hours. The 
present study shows the presence of the two peaks in CAD patients, and a more uniformly 
distribution during daylight hours in DCM patients (see Fig. 4). This conclusion is further 
supported by our observation that the timing of VT-onset in CAD and DCM populations are 
described by structurally different statistical models, with harmonic and polynomial 
regression providing the best fitting function in CAD and DCM, respectively. The finding 
that the circadian distribution of VT in CAD patients is better described by a harmonic 
function (such as a bimodal activity) may suggest that the underlying arrhythmogenic 
mechanism could be oscillating during the 24-hour period, as is the case of the autonomic 
sympathetic-vagal balance. This hypothesis is supported by Taneda et al. who described a 
much higher peak of VT in the morning in patients not taking beta-blockers vs. patients who 
did [Figure 2 in Taneda et al. 2001]. Similarly, Dorian suggested that sympathetic activation 
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can lead to a distributed shortening or, in some cases, prolonged action potential in the 
substrate, increasing the risk for reentrant arrhythmia [Dorian 2005].  
By contrast, the result that the DCM circadian distribution is polynomial rather than 
harmonic, may suggest a different underlying mechanism at the basis of VT initiation. The 
observation that almost all VT occur during the day-light and almost none during the night, 
might lead to the hypothesis that sympathetic tone could be involved. In fact, Pogwizd 
described that a cardiac preserved beta-receptor responsiveness might likely facilitate early 
and delayed after-depolarizations, and, consequently, a triggered activity [Pogwizd et al. 
2001, Pogwizd et al. 2004].  
Such considerations might lead to speculate that sympatho-vagal tone changings could 
facilitate a reentry in the CAD group, while a higher sympathetic tone could determine a 
dangerous triggered activity in the DCM one.  
It is noteworthy that the three different initiation patterns of VT episodes also show 
differences in the circadian distribution. (Figure 5 and Table 4).  
VT initiated with PM pattern are better described, in both DCM and CAD patients, by a 
polynomial model. Distribution is almost uniform during the observed 24 hours in the DCM 
group , while it is mostly focused during the night in the CAD group. Although the number 
of VT is small (7 PM-onset in CAD and 13 in DCM), the result in the CAD population may 
be consistent with a lower heart rate occurring during the night, promoting a greater anti-
bradycardia pacing intervention . It is less obvious to explain the finding in DCM, because 
the PM-onset occurs almost uniformly during the whole day. An increased prevalence of 
post-extrasystolic pauses distributed during the whole day, determining a frequent pacing 
escape, is more likely.  
Circadian distribution of SLS patterns are well described by a harmonic models in both 
CAD (R2 = 0.92 vs 0.77 for polynomial model) and DCM (R2 = 0.91 vs 0.68 for polynomial 
model) with VT initiation especially between 9 a.m. to 6 p.m. in CAD, while it is evident a 
very strong peak between 3 p.m. to 6 p.m. in DCM patients.  
Finally, the distribution of the PVC patterns is better described by a polynomial regression 
in the DCM group (R2=0.86 vs. 0.78 for harmonic regression) with a peak in the middle of 
the day and no VT during the night (hour range: 0-6 a.m. ); a different behavior is observed 
in the CAD group where a harmonic model fits slightly better (R2=0.84 vs. 0.83 for 
polynomial model ), with distribution showing small peaks between 9 a.m. and 12 a.m. and 
3 p.m. to 6 p.m. 
4.3 Limitations 
The main limitations of this registry lie in the small number of patients and in the lack of 
endomyocardial biopsy in the DCM group. In addition, only single chamber ICDs were 
considered: they may present increased risk of PM-onset vs dual and three-chamber ICDs 
[Sweeney et al. 2007]. About the pharmacological treatment, the only detailed information 
was referred to implant date: eventual changes, during the follow-up period, were not 
collected. 
Moreover, to examine the basal heart rhythm before the VT initiation, a good quality EGM 
at 250 Hz was obtained. As a consequence, for technical reasons, the ICD diagnostic 
parameters were programmed to store at the most three VT episodes. This setting, however, 
could have caused a lack of some episodes. For instance, in a DCM patient with some VT 
storms, successfully treated with the anti-tachycardia pacing, it was not possible to analyze 
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all the episodes, but only the latest ones. In order to limit these drawbacks, the same settings 
were used for CAD and DCM groups and the follow-up was performed periodically, 
(minimum of 3 to maximum 6 months) unless the ICD delivered a shock. In that case, the 
patient was invited to contact the hospital for a visit as soon as possible and data were 
retrieved by the ICD. It is authors’ opinion that the frequent follow-up could be sufficient to 
minimize the number of undetected VT episodes. 
5. Conclusion 
This study examines the differences between CAD and non-ischemic DCM patients with 
ICD. Our results show that patients with DCM exhibit a significantly higher prevalence of 
VT episodes (p<0.02) and a significantly greater variability in the VT initiation pattern 
(p<0.01). The circadian distribution (in a 3 –hour period analysis) of the VT-onset is also 
different in the two groups: CAD patients exhibit a morning peak: between 9 and 12 a.m. 
and an afternoon peak (around 6 p.m.), whereas DCM patients show a more uniform 
distribution during waking hours and very few episodes during the night.  
Eventually, no significant differences between CAD and DCM are observed from the 
analysis of VT-rate, coupling interval, prematurity index. Likewise, the analysis of the EGM 
signal during the 20 seconds immediately preceding VT onset show no significant 
differences in the heart-cycle, prevalence of PVC, nor prevalence of paced beats. 
This study (based on characterization of EGM, VT-onset and VT circadian distribution) does 
not define a relationship between observed CAD-DCM differences and underlying CAD-
DCM electrogenetic-mechanisms. Nevertheless, our findings suggest different foundations 
of VT initiation in patients with ischemic versus idiopathic dilated cardiomyopathy. 
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